pubmed-article:17869669 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17869669 | lifeskim:mentions | umls-concept:C1095909 | lld:lifeskim |
pubmed-article:17869669 | lifeskim:mentions | umls-concept:C0005528 | lld:lifeskim |
pubmed-article:17869669 | lifeskim:mentions | umls-concept:C0033262 | lld:lifeskim |
pubmed-article:17869669 | lifeskim:mentions | umls-concept:C0030054 | lld:lifeskim |
pubmed-article:17869669 | lifeskim:mentions | umls-concept:C0439857 | lld:lifeskim |
pubmed-article:17869669 | lifeskim:mentions | umls-concept:C0208407 | lld:lifeskim |
pubmed-article:17869669 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:17869669 | lifeskim:mentions | umls-concept:C2000378 | lld:lifeskim |
pubmed-article:17869669 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:17869669 | pubmed:dateCreated | 2007-9-17 | lld:pubmed |
pubmed-article:17869669 | pubmed:abstractText | To compare oxygen dependence and tissue transport properties of a new hypoxia-activated prodrug, PR-104A, with tirapazamine, and to evaluate the implications for antitumor activity when combined with radiotherapy. | lld:pubmed |
pubmed-article:17869669 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17869669 | pubmed:language | eng | lld:pubmed |
pubmed-article:17869669 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17869669 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17869669 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17869669 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17869669 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17869669 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17869669 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17869669 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17869669 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17869669 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17869669 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17869669 | pubmed:month | Oct | lld:pubmed |
pubmed-article:17869669 | pubmed:issn | 0360-3016 | lld:pubmed |
pubmed-article:17869669 | pubmed:author | pubmed-author:WilsonWilliam... | lld:pubmed |
pubmed-article:17869669 | pubmed:author | pubmed-author:HicksKevin... | lld:pubmed |
pubmed-article:17869669 | pubmed:author | pubmed-author:PattersonAdam... | lld:pubmed |
pubmed-article:17869669 | pubmed:author | pubmed-author:PatelKashyapK | lld:pubmed |
pubmed-article:17869669 | pubmed:author | pubmed-author:SiimBronwyn... | lld:pubmed |
pubmed-article:17869669 | pubmed:author | pubmed-author:PruijnFrederi... | lld:pubmed |
pubmed-article:17869669 | pubmed:author | pubmed-author:MyintHilaryH | lld:pubmed |
pubmed-article:17869669 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17869669 | pubmed:day | 1 | lld:pubmed |
pubmed-article:17869669 | pubmed:volume | 69 | lld:pubmed |
pubmed-article:17869669 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17869669 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17869669 | pubmed:pagination | 560-71 | lld:pubmed |
pubmed-article:17869669 | pubmed:dateRevised | 2007-12-3 | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:meshHeading | pubmed-meshheading:17869669... | lld:pubmed |
pubmed-article:17869669 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17869669 | pubmed:articleTitle | Oxygen dependence and extravascular transport of hypoxia-activated prodrugs: comparison of the dinitrobenzamide mustard PR-104A and tirapazamine. | lld:pubmed |
pubmed-article:17869669 | pubmed:affiliation | Auckland Cancer Society Research Centre, University of Auckland School of Medical Sciences, Auckland, New Zealand. k.hicks@auckland.ac.nz | lld:pubmed |
pubmed-article:17869669 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17869669 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:17869669 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:17869669 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17869669 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17869669 | lld:pubmed |